FBIOP.PFD (Fortress Biotech) Accounts Payable & Accrued Expense : $64.64 Mil (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Fortress Biotech Accounts Payable & Accrued Expense?

Fortress Biotech's quarterly accounts payable & accrued expense increased from Sep. 2024 ($61.92 Mil) to Dec. 2024 ($63.31 Mil) and increased from Dec. 2024 ($63.31 Mil) to Mar. 2025 ($64.64 Mil).

Fortress Biotech's annual accounts payable & accrued expense declined from Dec. 2022 ($94.48 Mil) to Dec. 2023 ($70.33 Mil) and declined from Dec. 2023 ($70.33 Mil) to Dec. 2024 ($63.31 Mil).

Fortress Biotech Accounts Payable & Accrued Expense Historical Data

The historical data trend for Fortress Biotech's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fortress Biotech Accounts Payable & Accrued Expense Chart

Fortress Biotech Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

42.81

87.77

94.48

70.33

63.31

Fortress Biotech Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															74.42	66.51	61.92	63.31	64.64

Fortress Biotech Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Fortress Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fortress Biotech Inc (NAS:FBIOP.PFD) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

FBIO:USA CNB0.PFD:Germany

Address

1111 Kane Concourse, Suite 301, Bay Harbor Island, FL, USA, 33154

Website

https://www.fortressbiotech.com

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.